Research
Prevention of hepatocellular carcinoma with antiviral therapy
Abstract
Chronic viral hepatitis types B and C may eventually lead to the development of hepatocellular carcinoma. Although hepatitis B is readily preventable by vaccination, there is growing evidence that antiviral therapy directed against hepatitis B may reduce the risk of liver cancer among those already infected. There is no vaccine against hepatitis C, but the evidence is now strong that antiviral therapy with sustained virological response (viral cure) reduces, but does not eliminate, the risk of hepatocellular carcinoma.
Author's affiliations
AM Di Bisceglie, Department of Internal Medicine, Saint Louis University School of Medicine, Missouri, USA
Full Text
PDF (112KB)Cite this article
Article History
Date published: 2018-08-08
Article Views
Full text views: 664
Comments on this article
*Read our policy for posting comments here